BNET Industries
- Private
Contact Information
NAICS Code Colleges, Universities, and Professional Schools: 611310
Recent Events
-
UTSA adopts Click Commerce’s research, compliance software
-
Sole Finalist Named for UTPA President Position
-
Collaboration creates 250 jobs in Richardson
-
Gophers to Play Texas at TCF Bank Stadium in 2015
-
Tech research at UT in line for $2M in funding
-
Tech receives $21.5 million bonus from state for research
-
RF Code Announces First Ever Wire-Free Liquid Detection Sensor
-
In the race to turn back the biological clock, consumers are reaching for an unproven...
-
TerraTherm, Inc.: TerraTherm Royalty Payments to The University of Texas at Austin Top $1 Million...
-
Dallas-based Rainbow Days to put on Kids University summer camp
News & Analysis
Filter by
austin and patent and university of texas - All News and Analysis
Adenoviral vector patent issued to University of Texas.
- 2004-01-01
Introgen Therapeutics (Austin, TX) announced that a patent directed to classes of adenoviral vectors has been awarded to the University of Texas (Austin, TX) and is exclusively licensed to Introgen. These classes of adenoviral vectors are particularly important in the commercial production of adenovirus...
Introgen's anti-cancer therapy in combination with established cancer treatments awarded patent.(Brief Article)
- 2001-09-01
The University of Texas (Austin, TX; 512-499-4462) and Introgen Therapeutics, Inc. (Austin, TX; 512-708-9310) announced that the United States Patent and Trademark Office has issued to the Board of Regents of The University of Texas System United States Patent 6,271,207 titled "Enhanced Expression of Transgenes."...
Introgen's viral vector technology awarded patent.(Introgen Therapeutics Inc. licenses patent from the University of Texas on hindering viruses)(Brief Article)
- 2000-11-01
The University of Texas (Austin, TX; 512-499-4462) and Introgen Therapeutics, Inc. (Austin, TX; 512-708-9310) announced that the United States Patent and Trademark Office has issued to The University of Texas United States Patent 6,110,744, titled, "Diminishing Viral Gene Expression By Promoter Replacement." The patent...
University of Texas applies for patent.(method for treating thrombocytopenia)(Brief Article)
- 2000-11-01
University of Texas (Austin, TX) has applied for a patent covering a method for treating thrombocytopenia in a mammal through administration of thrombopoietin to raise platelet levels. (US Appl. 244370; WO Publication 200044398)
University of Texas obtains United States patent.(Brief Article)
- 2000-09-01
University of Texas (Austin, TX) patented methods of producing eukaryotic disulfide bondcontaining polypeptides in bacterial hosts, and compositions resulting therefrom. Co-expression of a eukaryotic foldase and a disulfide bond-containing polypeptide in a bacterial host cell is demonstrated. (US 6027888)
University of Texas obtains United States patent.(Brief Article)
- 2000-07-01
University of Texas (Austin, TX) has patented methods and compositions for the selective manipulation of gene expression through the preparation of retroviral expression vectors for expressing antisense sequences, such as K-ras oncogene antisense sequences, or sequences encoding a desired product, such as wild type p53 sequences....
- 1
Glass Door
| Company | Employer Rating |
| Alcoa |  |
| CBS Corp |  |
| Johnson & Johnson | |
| Costco Wholesale |  |
|
IndustryTop Rated
